These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7355345

  • 1. Cyproheptadine therapy in Cushing's disease and Nelson's syndrome.
    Jialal I, Pillay NL.
    S Afr Med J; 1980 Mar 01; 57(9):305. PubMed ID: 7355345
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyproheptadine in Nelson's syndrome.
    Cassar J, Mashiter K, Joplin GF, Rees LH, Gilkes JJ.
    Lancet; 1976 Aug 21; 2(7982):426. PubMed ID: 73893
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.
    Reincke M, Allolio B, Kaulen D, Jaursch-Hancke C, Winkelmann W.
    Klin Wochenschr; 1988 Aug 01; 66(15):686-9. PubMed ID: 2845188
    [Abstract] [Full Text] [Related]

  • 8. Nelson's syndrome after Cushing's disease in childhood: a continuing problem.
    Thomas CG, Smith AT, Benson M, Griffith J.
    Surgery; 1984 Dec 01; 96(6):1067-77. PubMed ID: 6505960
    [Abstract] [Full Text] [Related]

  • 9. The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease.
    Lamberts SW, Uitterlinden P, Klijn JM.
    Acta Endocrinol (Copenh); 1989 Jun 01; 120(6):760-6. PubMed ID: 2543178
    [Abstract] [Full Text] [Related]

  • 10. Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.
    Casulari LA, Naves LA, Mello PA, Pereira Neto A, Papadia C.
    Horm Res; 2004 Jun 01; 62(6):300-5. PubMed ID: 15557761
    [Abstract] [Full Text] [Related]

  • 11. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO, Pereira AM, van den Berg G, Romijn JA, Veldhuis JD, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 Jun 01; 60(6):765-72. PubMed ID: 15163342
    [Abstract] [Full Text] [Related]

  • 12. Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.
    Loli P, Berselli ME, Frascatani F, Muratori F, Tagliaferri M.
    J Endocrinol Invest; 1984 Apr 01; 7(2):93-6. PubMed ID: 6327800
    [Abstract] [Full Text] [Related]

  • 13. [Is it possible to predict the development of Nelson's syndrome in Cushing's disease after bilateral adrenalectomy?].
    Horký K, Kanka J, Gregorová I, Tomsová Z, Dvoráková J.
    Cas Lek Cesk; 1990 May 25; 129(21):645-9. PubMed ID: 2164450
    [Abstract] [Full Text] [Related]

  • 14. [Nelson's syndrome management: current knowledge].
    Garcia C, Bordier L, Garcia-Hejl C, Ceppa F, Mayaudon H, Dupuy O, Bauduceau B.
    Rev Med Interne; 2007 Nov 25; 28(11):766-9. PubMed ID: 17574308
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome.
    Mercado-Asis LB, Yanovski JA, Tracer HL, Chik CL, Cutler GB.
    J Clin Endocrinol Metab; 1997 Feb 25; 82(2):514-7. PubMed ID: 9024246
    [Abstract] [Full Text] [Related]

  • 18. Cortisol and androgen secretion in a case of Nelson's syndrome with paratesticular tumors: response to cyproheptadine therapy.
    Krieger DT, Samojlik E, Bardin CW.
    J Clin Endocrinol Metab; 1978 Oct 25; 47(4):837-44. PubMed ID: 233683
    [Abstract] [Full Text] [Related]

  • 19. [Drug treatment of Cushing's syndrome with cyproheptadine].
    Seyer-Hansen K, Weeke J, Møller J.
    Ugeskr Laeger; 1979 Sep 10; 141(37):2518-20. PubMed ID: 483437
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.